Baku, Azerbaijan, Jan. 29
By Sara Israfilbayova - Trend:
A syringe plant of Azerbaijan’s Diamed Co will begin production in March, founder of the company Ayten Guliyeva told Trend on Jan. 29.
Guliyeva stressed that in the first year of operation, the plant will focus on the domestic demand.
"The annual demand in the country is 170 million syringes,” she said. “In the first six months, we plan to produce 100 million syringes and further increase production to 150-170 million syringes."
Guliyeva stressed that presently, the main goal is to minimize the import of syringes.
“The export of syringes produced by the plant is planned to be arranged in the coming years,” she added.
The plant of Diamed Co is being built in the Pirallahi Industrial Park. The Pirallahi Industrial Park, established in 2016, specializes in the production of pharmaceutical products. Investors are exempt from paying various taxes and customs duties for seven years in the Pirallahi Industrial Park as in other industrial parks.
Four residents operate in the Pirallahi Industrial Park, namely, Hayat Pharm (a joint Azerbaijani-Russian plant), Caspian Pharmed (a joint Azerbaijani-Iranian plant), a plant of Diamed Co and a plant of IFFA.
---
Follow the author on Twitter: @IsrafilbekovaS
